• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

姑息治疗住院环境中精神疾病的筛查:医院焦虑抑郁量表与一般健康问卷-12的比较

Screening for psychiatric illness in the palliative care inpatient setting: a comparison between the Hospital Anxiety and Depression Scale and the General Health Questionnaire-12.

作者信息

Le Fevre P, Devereux J, Smith S, Lawrie S M, Cornbleet M

机构信息

Royal Edinburgh Hospital, UK.

出版信息

Palliat Med. 1999 Sep;13(5):399-407. doi: 10.1191/026921699671260095.

DOI:10.1191/026921699671260095
PMID:10659112
Abstract

The objective of this study was to compare the performance of the Hospital Anxiety and Depression Scale (HADS) with the 12-item General Health Questionnaire (GHQ-12) as a screening instrument for the detection of psychiatric disorders in a palliative care inpatient setting. The results from the HADS and GHQ were compared to diagnoses generated from a semistructured psychiatric interview (Revised Clinical Interview Schedule) using standard receiver operating characteristic analysis. The study was conducted at the Marie Curie Centre, Edinburgh, a 37-bedded palliative care inpatient facility. Out of a total of 282 admissions during the study period, 79 took part in the study. The remainder of patients either refused (69) or were too unwell to participate (134). The HADS was found to be an effective screening tool for identifying depression, with an area under the receiver operating characteristic curve of 0.92. A suggested cut-off of 20 would have a sensitivity of 0.77, a specificity of 0.85 and a positive predictive value (PPV) of 0.48. There was no significant difference between the two subscales in their ability to detect depressive illnesses, although there was a trend for the anxiety subscale to perform better (P < 0.15). The GHQ did not perform as well as the HADS in this type of population. In view of this, it can be concluded that the HADS is a valid screening tool for psychiatric disorders, particularly depression, in a palliative care setting.

摘要

本研究的目的是比较医院焦虑抑郁量表(HADS)与12项一般健康问卷(GHQ - 12)作为姑息治疗住院患者精神障碍筛查工具的性能。使用标准的受试者工作特征分析,将HADS和GHQ的结果与通过半结构化精神科访谈(修订临床访谈时间表)得出的诊断结果进行比较。该研究在爱丁堡的玛丽居里中心进行,这是一家拥有37张床位的姑息治疗住院机构。在研究期间的282例入院患者中,79例参与了研究。其余患者要么拒绝参与(69例),要么病情太重无法参与(134例)。结果发现,HADS是识别抑郁症的有效筛查工具,受试者工作特征曲线下面积为0.92。建议的临界值为20时,灵敏度为0.77,特异度为0.85,阳性预测值(PPV)为0.48。两个分量表在检测抑郁性疾病的能力上没有显著差异,尽管焦虑分量表有表现更好的趋势(P < 0.15)。在这类人群中,GHQ的表现不如HADS。鉴于此,可以得出结论,HADS是姑息治疗环境中精神障碍尤其是抑郁症的有效筛查工具。

相似文献

1
Screening for psychiatric illness in the palliative care inpatient setting: a comparison between the Hospital Anxiety and Depression Scale and the General Health Questionnaire-12.姑息治疗住院环境中精神疾病的筛查:医院焦虑抑郁量表与一般健康问卷-12的比较
Palliat Med. 1999 Sep;13(5):399-407. doi: 10.1191/026921699671260095.
2
Screening for anxiety and depression in dialysis patients: comparison of the Hospital Anxiety and Depression Scale and the Beck Depression Inventory.透析患者焦虑和抑郁的筛查:医院焦虑和抑郁量表与贝克抑郁量表的比较。
J Psychosom Res. 2012 Aug;73(2):139-44. doi: 10.1016/j.jpsychores.2012.04.015. Epub 2012 Jun 11.
3
Screening for mental disorders in cancer, cardiovascular and musculoskeletal diseases. Comparison of HADS and GHQ-12.癌症、心血管疾病和肌肉骨骼疾病中精神障碍的筛查。医院焦虑抑郁量表(HADS)与一般健康问卷-12(GHQ-12)的比较。
Soc Psychiatry Psychiatr Epidemiol. 2006 Jan;41(1):56-62. doi: 10.1007/s00127-005-0992-0. Epub 2006 Jan 1.
4
[The accuracy of HADS and GHQ-12 in detecting psychiatric morbidity in breast cancer patients].[医院焦虑抑郁量表(HADS)和一般健康问卷-12项版(GHQ-12)在检测乳腺癌患者精神疾病方面的准确性]
Turk Psikiyatri Derg. 2010 Spring;21(1):49-59.
5
Diagnostic validity of the Hospital Anxiety and Depression Scale (HADS) in cancer and palliative settings: a meta-analysis.癌症和姑息治疗环境中医院焦虑和抑郁量表(HADS)的诊断有效性:荟萃分析。
J Affect Disord. 2010 Nov;126(3):335-48. doi: 10.1016/j.jad.2010.01.067. Epub 2010 Mar 5.
6
Validation of the Hospital Anxiety and Depression Scale in patients with epilepsy.医院焦虑抑郁量表在癫痫患者中的效度验证。
Epilepsy Behav. 2016 May;58:97-101. doi: 10.1016/j.yebeh.2016.03.003. Epub 2016 Apr 9.
7
Comparing the hospital anxiety and depression scale to the Brief Edinburgh Depression Scale for identifying cases of major depressive disorder in advanced cancer palliative patients.比较医院焦虑和抑郁量表与简短爱丁堡抑郁量表,以识别晚期癌症姑息治疗患者中的重度抑郁症病例。
Palliat Support Care. 2021 Apr;19(2):170-174. doi: 10.1017/S1478951520000760.
8
A study of the psychometric properties of the Beck Depression Inventory-II, the Montgomery and Åsberg Depression Rating Scale, and the Hospital Anxiety and Depression Scale in a sample from a healthy population.对来自健康人群样本的贝克抑郁量表第二版、蒙哥马利-Åsberg抑郁评定量表和医院焦虑抑郁量表的心理测量学特性的研究。
Scand J Psychol. 2014 Feb;55(1):83-9. doi: 10.1111/sjop.12090. Epub 2013 Nov 21.
9
An evaluation of two self-report screening measures for mood in an out-patient chronic heart failure population.对门诊慢性心力衰竭患者群体中两种情绪自我报告筛查方法的评估。
Int J Geriatr Psychiatry. 2007 Nov;22(11):1147-53. doi: 10.1002/gps.1807.
10
Reliability and validity of a Chinese version of the HADS for screening depression and anxiety in psycho-cardiological outpatients.中文版 HADS 在心理心脏病门诊患者中筛查抑郁和焦虑的信度和效度。
Compr Psychiatry. 2014 Jan;55(1):215-20. doi: 10.1016/j.comppsych.2013.08.012. Epub 2013 Oct 7.

引用本文的文献

1
Hospital Anxiety and Depression Scale Anxiety subscale (HADS-A) for detecting anxiety disorders in adults.用于检测成人焦虑症的医院焦虑抑郁量表焦虑分量表(HADS-A)
Cochrane Database Syst Rev. 2025 Jul 2;7(7):CD015456. doi: 10.1002/14651858.CD015456.
2
A Web-Based Mindfulness-Based Cognitive Therapy for Couples Dealing With Chronic Cancer-Related Fatigue: Protocol for a Single-Arm Pilot Trial.一种基于网络的正念认知疗法,用于应对慢性癌症相关疲劳的夫妻:单臂试点试验方案。
JMIR Res Protoc. 2023 Nov 6;12:e48329. doi: 10.2196/48329.
3
Development and Validation of Total Pain Scale for Evaluation of Total Pain in Cancer Patients.
癌症患者总体疼痛评估的总体疼痛量表的开发与验证
Indian J Palliat Care. 2023 Jul-Sep;29(3):312-323. doi: 10.25259/IJPC_256_2022. Epub 2023 Jul 11.
4
Consultation-Liaison Case Conference: Suicidal Ideation in a Patient at the End-of-Life.会诊-联络病例讨论会:一名临终患者的自杀意念
J Acad Consult Liaison Psychiatry. 2023 Jul-Aug;64(4):371-382. doi: 10.1016/j.jaclp.2022.11.004. Epub 2022 Dec 7.
5
How best to capture the impact of complementary therapies in palliative care: A systematic review to identify and assess the appropriateness and validity of multi-domain tools.如何最好地捕捉姑息治疗中补充疗法的影响:一项系统评价,旨在确定和评估多领域工具的适当性和有效性。
Palliat Med. 2022 Oct;36(9):1320-1335. doi: 10.1177/02692163221122955. Epub 2022 Sep 7.
6
The performance of the EQ-5D-3L in screening for anxiety and depressive symptoms in hospital and community settings.EQ-5D-3L 在医院和社区环境中筛查焦虑和抑郁症状的性能。
Health Qual Life Outcomes. 2021 Mar 19;19(1):96. doi: 10.1186/s12955-021-01731-x.
7
Factor Structures of General Health Questionnaire-12 Within the Number of Kins Among the Rural Residents in China.中国农村居民亲属数量范围内一般健康问卷-12的因子结构
Front Psychol. 2019 Aug 2;10:1774. doi: 10.3389/fpsyg.2019.01774. eCollection 2019.
8
Core Symptoms of Major Depressive Disorder among Palliative Care Patients.姑息治疗患者中重度抑郁症的核心症状。
Int J Environ Res Public Health. 2018 Aug 16;15(8):1758. doi: 10.3390/ijerph15081758.
9
Measuring health-related quality of life in patients with advanced cancer: a systematic review of self-administered measurement instruments.测量晚期癌症患者的健康相关生活质量:自我管理测量工具的系统评价。
Qual Life Res. 2018 Aug;27(8):1937-1955. doi: 10.1007/s11136-018-1809-4. Epub 2018 Feb 10.
10
'Worried to death': the assessment and management of anxiety in patients with advanced life-limiting disease, a national survey of palliative medicine physicians.“忧心忡忡”:对晚期生命有限疾病患者焦虑的评估和管理,对姑息治疗医师的全国性调查。
BMC Palliat Care. 2017 Dec 11;16(1):69. doi: 10.1186/s12904-017-0245-5.